Literature DB >> 8201306

Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study.

B J Cuffel1, P Chase.   

Abstract

Recent studies of the effectiveness of specialized programs that treat substance use disorders in schizophrenia have obtained promising results but have not involved control groups. Interpretation of these apparently positive results is problematic because remission and relapse rates of substance use disorders have not been reported in this population. The present study reports 1-year rates of substance abuse and dependence remission and relapse in a sample of schizophrenics taken from the Epidemiologic Catchment Area study. Results indicated that the prevalence of substance use disorders in schizophrenia remained constant over the year primarily because rates of remission were balanced by rates of relapse. Individuals who developed abuse or dependence over the year were younger, male, and showed increases in depression and risk for hospitalization over the year. Individuals who remitted abuse or dependence were older, female, and showed decreases in depression over the year. Dual diagnosis treatment programs have recently reported higher rates of remission than were evidenced in this sample, thus providing preliminary support for the effectiveness of these treatments.

Entities:  

Mesh:

Year:  1994        PMID: 8201306     DOI: 10.1097/00005053-199406000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

1.  Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status.

Authors:  Kate B Carey; Michael P Carey; Jeffrey S Simons
Journal:  J Nerv Ment Dis       Date:  2003-05       Impact factor: 2.254

2.  Inpatient stays for patients diagnosed with severe psychiatric disorders and substance abuse.

Authors:  C J Bradley; G A Zarkin
Journal:  Health Serv Res       Date:  1996-10       Impact factor: 3.402

3.  Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.

Authors:  Yasemin Tekin Uludağ; Gülcan Güleç
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

4.  Patterns and Predictors of Changes in Substance Use in Individuals with Schizophrenia and Affective Disorders.

Authors:  Melanie E Bennett; Clayton H Brown; Jason Peer; Lan Li; Alan S Bellack
Journal:  J Dual Diagn       Date:  2012-02-13

Review 5.  Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.

Authors:  Sandra L Tunis; Haya Ascher-Svanum; Michael Stensland; Bruce J Kinon
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.

Authors:  Melanie E Bennett; Alan S Bellack; Clayton H Brown; Carlo DiClemente
Journal:  Addict Behav       Date:  2009-03-27       Impact factor: 3.913

7.  Use of Legal Drugs by Psychiatric Outpatients: Benefits, Costs, and Change.

Authors:  Kate B Carey; Stephen A Maisto; Michael P Carey; Christopher M Gordon; Christopher J Correia
Journal:  Cogn Behav Pract       Date:  1999

Review 8.  Effect of Case Management Interventions for Patients with Substance Use Disorders: A Systematic Review.

Authors:  Louise Penzenstadler; Ariella Machado; Gabriel Thorens; Daniele Zullino; Yasser Khazaal
Journal:  Front Psychiatry       Date:  2017-04-06       Impact factor: 4.157

9.  Risky use of alcohol, drugs and cigarettes in a psychosis unit: a 1 1/2 year follow-up of stability and changes after initial screening.

Authors:  Gunilla Cruce; Agneta Ojehagen
Journal:  BMC Psychiatry       Date:  2007-07-06       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.